Milestone Pharmaceuticals Statistics
NASDAQ: MISTHealthcareBiotechnologyUSD
0.7121-0.0451 (-5.96%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Milestone Pharmaceuticals by the numbers
Milestone Pharmaceuticals has a market capitalization of $88.7 million based on 124.50M shares outstanding. With trailing EPS of $-0.68, Milestone Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.3% below its 50-day average and 51.8% below its 200-day average.
Average daily trading volume is 1.40M shares, or about $994,514 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MIST valuation vs. peer median
| Metric | MIST | Peer median | Difference |
|---|---|---|---|
| Market cap | $88.66M | $89.35M | -1% |
| Avg. volume | 1.40M | 102.62K | +1261% |
Peer median across 8 companies: ICCC, NMRA, RLYB, EQ, CGTX, NRXS, ATRA, TELO.
Valuation
- Market cap
- $88.66M
- EPS (TTM)
- $-0.68
- Shares outstanding
- 124.50M
Price and trading
- Previous close
- 0.7572
- Open
- 0.769
- Day range
- 0.7096 – 0.769
- 52-week range
- 0.709 – 3.06
- 52-week change
- -64.39%
- Beta
- —
- Volume
- 1.37M
- Average volume
- 1.40M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 88.66M
- Forward Pe
- -0.92
- Eps
- -0.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.06
- Week52 Low
- 0.71
- Avg Volume
- 1.40M
- Shares Outstanding
- 124.50M
- Ma50
- 1.02
- Ma200
- 1.48
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -76.73%
- Pct From52w Low
- 0.44%